Although prevention of HIV infection by CD8+ T cells may be unrealistic, a T cell-based vaccine might limit early viral dissemination and immune damage by controlling HIV more effectively during initial infection, thereby leading to slower progression to AIDS [10]. The gene discussed is CD8A; the disease is HIV infectious disease.